Key facts
- Avation Medical’s last known valuation is $55.2M (Feb 2024).
- It has raised $38.1M across 1 recorded rounds; the latest was Early Stage VC ($12.9M) in Feb 2020.
- Notable investors include JobsOhio Ventures, ShangBay Capital, Arboretum Ventures, Angelini Ventures, Asahi Kasei — 9 tracked in total.
- Avation Medical has filed 2 Form Ds with the SEC since 2020, most recently Feb 2021 ($12.9M sold to 17 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Avation Medical
Funding rounds
1 roundsAbout Avation Medical
Developer of wearable nerve modulation systems designed to offer patient-friendly nerve stimulation therapies. The company's wearable systems permit personalized and customized care and re-imagining of neuromodulation by developing approaches based on proven technologies, enabling patients to have elevated care with chronic conditions.
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2016
- Employees
- 91
- Website
- avation.com/
- Ownership
- Privately Held (backing)
Avation Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avation Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avation Medical in its N-PORT filings yet. We sweep new filings monthly.